ArticleFarmaceuticos comunitarios2026
Comprehensive management of a chronic patient in community pharmacy: impact of Comprehensive Medication Management on health outcomes and quality of life.
Article in Farmaceuticos comunitarios, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 56-year-old male with asthma, ischemic heart disease, and hyperuricemia attended the San Francisco Javier Pharmacy with knee and ankle swelling problem. Through the implementation of Comprehensive Medication Management (CMM), a patient-centered intervention was developed that included in-depth interviews, pharmacotherapy review, and collaboration with primary care. Eight drug-related problems (DRPs) were identified, six of which were resolved, highlighting the disappearance of joint symptoms that were highly limiting to daily life. Clinical and functional improvements were observed, along with a significant enhancement in health-related quality of life indicators assessed using the EQ-5D-5L questionnaire. The patient reported an increase in EQ-VAS from 10 to 90 and a gain in quality-adjusted life years (QALYs). This case highlights the effectiveness of CMM in optimizing therapeutic outcomes and improving quality of life in complex patients with polypharmacy. It also reinforces the value of community pharmacies as accessible health agents capable of delivering integrated, biopsychosocial care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.